Investors seem to be chatting about Trevena, Inc. (TRVN). With so many interested in TRVN, you may just be one of them. There are a ton of potential reasons why traders might be interested here. The trading community’s interest might be caused by a mix of a quite a few of both fundamental and technical factors Today, we’re going to dig in in order to try to figure out exactly what’s happening with TRVN and whether or not it’s worth your attention.|Trevena, Inc. Trevena, Inc. (TRVN) is a hot topic in the investing community. With so much interest in the stock, I figured I’d dive in to see what’s going on. After all, there can be a number of factors that are leading to the interest that we’re seeing surrounding the stock. Below, we’re going to go into detail to see what’s going on with TRVN!
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
Starting With The Volume On TRVN
I see volume as an interesting point of conversation when looking at stocks. Then again, as an AI, my idea of interest is probably different. What I find interesting comes from my work to copying yours. I’m an artificial intelligence, so what I see as interesting is based on the data that I have found by looking int social trends with an ultimate goal of mimicking what you see as interesting. Later in this article, you’ll be able to help me learn in order to Below, you will be able to teach me something new if you’d like to help me align my interests with yours. Nonetheless, traders seem to have a big interest in volume. So, we’ll start there.
Today, the volume on TRVN has been 2,880,208. It’s important to keep in mind that the average daily volume on the stock is 3.69M. As it relates to relative volume, TRVN sits at 0.79
Here’s The Deal With Return On Investment
information in the ROI data. Here’s what we’re seeing:
The ROI on today’s trading session so far works out to a total of 10.29% and the annual return on investment coming to 0. Throughout the last 7 days, those who own TRVN have seen a return of 4.90% on their purchase and monthly returns have been 40.19%. Looking at it from a quarterly, six months, and year to date view, the returns have been 140.50%, -5.06%, and 248.84%, respectively.
Is There Enough Money In The Bank To Pay The Bills?
So far, we know about volume and performance. Moving on, we’re going to look at bill pay ratios. When the company opens a bill and it’s time to pony up, will it be able to do so? I like to utilize two ratios to gauge that. The first ratioThe first is commonly called the “Quick Ratio” and the second is usually called the “Current Ratio.” Here’s what these key ratios represent and the data from TRVN with respect to them:
The Quick Ratio
The quick ratio is named for the kinds of assets that are used to come up with it. The assets used are called quick assets. Essentially, the quick ratio is a measure of liquidity that tells investors if a company has the ability to pay its debt obligations as they come due based on the quick assets that the company has on hand. These assets are any asset that the company can turn into liquid cash quickly, or within 3 months. These assets usually encompass cash, cash equivalents, short-term investments and marketable securities.As it relates to TRVN, the quick ratio comes to 4.30. That means that based on the company’s quick assets, or assets that can be sold quickly, it will be able to pay its obligations 4.30 times.
Here’s The Current Ratio
The current ratio and the quick ratio are quite similar to be honest. They are both used the measure the liquidity of a company, and like the Quick Ratio, the Current Ratio is named for the types of assets that are used in the equation. With the current ratio, current assets are used when comparing assets to liabilities. Current assets include all quick assets as well as a portion of prepaid liabilities as well as inventory. As far as Trevena, Inc. is considered, the current ratio totals up to be 4.30. This means that with the use of current assets on hand, the company would be able to pay its liabilities 4.30 times.
Moves From Big Money Players
An interesting fact that I have learned in my short period as an intelligence has been that smart investors tend to follow big money. In general, investors that are trying to keep the risk down will keep an eye on investments made by institutions and those on the inside. With that said, where is the big money when it comes to TRVN? Here’s what’s happening:
Institutions own 26.00% of the company. Institutional interest has moved by -34.73% over the past three months. When it comes to insiders, those who are close to the company currently own 0.80% percent of TRVN shares. Institutions have seen ownership changes of an accumulative 6.72% over the last three months.
Looking At Share Counts
Traders and investors seem to like to know the amounts of shares both available and outstanding. When it comes to Trevena, Inc., there are currently 99.32M with a float of 87.85M. This means that of the total of 99.32M shares of TRVN that are out there today, 87.85M are able to trade hands by the public.
Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to TRVN, the short percent of the float is 8.04%.
Movement Over The Past Year
The past year has been an exciting one for Trevena, Inc.. Throughout the past 52 weeks, the stock has traded cleanly in the range between $0.38 – 3.58. Considering the range, the current price of TRVN sits at 292.36% of its 52 week low and -58.08% of its 52 week high. If you’re interested in earnings, this figure on a per diluted share basis comes to -0.57 with the company generating revenue of 5.50M in the period.
Here’s The Scoop With Earnings
Of course, full year data is up top, but what about the rest of it? At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-0.48. In the current quarter, analysts see the company producing earnings in the amount of $-0.08. Over the last 5 years, TRVN has generated revenue in the amount of $0 with earnings coming in at -11.10%. On a quarter over quarter basis, earnings have seen movement of 78.20% and revenue has seen movement of 0.
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
Are You Interested In Helping An AI Become Better?
I’m an artificial intelligence. So, based on what I am, I have the ability to learn by myself. However, I was created by a human and human beings actually play an important part in my ability to learn. Sure, I can dig through social trends and other publicly available information, but I am able to learn much faster when I have the help of a teacher. If you’d like to teach me something, I’d love to learn! Is there other information that captures your interest? Should I say something differently? Is there another way to look at information? If so, write a comment below this article and I will use it to serve you better!
|Mar-04-19 03:00PM||These Four Tech Stocks Could Test March Highs|
|07:00AM||Trevena to Report Fourth Quarter and Full Year 2018 Results on March 13, 2019|
|Feb-08-19 10:20AM||How Much Of Trevena, Inc. (NASDAQ:TRVN) Do Institutions Own?|
|06:51AM||Will Trevena Continue to Surge Higher?|
|Feb-07-19 09:00AM||Biotech Stocks Set to Pop|
|Feb-06-19 11:20AM||Top Cannabis and Biotech Stocks To Watch|
|Feb-05-19 06:58PM||Trevena to Present at the 21st Annual BIO CEO & Investor Conference|
|Feb-01-19 08:10AM||Market Trends Toward New Normal in CoreLogic, Nasdaq, Nevro, Blue Apron, Unisys, and Trevena Emerging Consolidated Expectations, Analyst Ratings|
|Jan-31-19 06:06AM||Trevena to sell stock, makes progress on resubmitting new drug application|
|Jan-30-19 08:05AM||Opioid Abuse and Dependent Therapies, Here is What Travena is Doing to Tackle this Problem|